Published on Feb 8, 2016
Several
years ago, the biotech company Novartis came to Microsoft because they
had seen the Kinect system for Xbox game consoles and thought the body
movement sensors might be helpful for tracking the progression of
multiple sclerosis.
years ago, the biotech company Novartis came to Microsoft because they
had seen the Kinect system for Xbox game consoles and thought the body
movement sensors might be helpful for tracking the progression of
multiple sclerosis.
That, in turn, could help them more consistently
judge whether a treatment they were proposing was working.
judge whether a treatment they were proposing was working.
Microsoft
researchers were intrigued, and called upon their experts in machine
learning to create algorithms that could more accurately measure the
subtle changes in movement that can occur as MS progresses.
researchers were intrigued, and called upon their experts in machine
learning to create algorithms that could more accurately measure the
subtle changes in movement that can occur as MS progresses.
The Assess
MS project also brought in Microsoft’s experts in human-computer
interaction, who were able to help design a specialized system that
would work in a real-world hospital setting, where medical professionals
with no specialized technical skills would be asked to operate the
machine in cramped exam rooms.
MS project also brought in Microsoft’s experts in human-computer
interaction, who were able to help design a specialized system that
would work in a real-world hospital setting, where medical professionals
with no specialized technical skills would be asked to operate the
machine in cramped exam rooms.
The collaboration between Microsoft
Research’s Cambridge, UK, lab and Novartis holds the promise of helping
doctors more quickly bring better treatments to patients who are
suffering from MS, by offering more consistent analysis of whether the
treatments are helping patients.
Learn more:
http://news.microsoft.com/?p=277881
http://research.microsoft.com
Research’s Cambridge, UK, lab and Novartis holds the promise of helping
doctors more quickly bring better treatments to patients who are
suffering from MS, by offering more consistent analysis of whether the
treatments are helping patients.
Learn more:
http://news.microsoft.com/?p=277881
http://research.microsoft.com
Category - Science + Technology
License -- Standard YouTube License
No comments:
Post a Comment